Branko Cuglievan

2.4k total citations
79 papers, 562 citations indexed

About

Branko Cuglievan is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Branko Cuglievan has authored 79 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 28 papers in Public Health, Environmental and Occupational Health and 24 papers in Hematology. Recurrent topics in Branko Cuglievan's work include Acute Lymphoblastic Leukemia research (27 papers), Acute Myeloid Leukemia Research (20 papers) and CAR-T cell therapy research (17 papers). Branko Cuglievan is often cited by papers focused on Acute Lymphoblastic Leukemia research (27 papers), Acute Myeloid Leukemia Research (20 papers) and CAR-T cell therapy research (17 papers). Branko Cuglievan collaborates with scholars based in United States, Italy and Netherlands. Branko Cuglievan's co-authors include Michael Roth, David McCall, Joseph A. Ludwig, Salah-Eddine Lamhamedi-Cherradi, Brian A. Menegaz, J. Andrew Livingston, Amy M. Berkman, Clark R. Andersen, Vivek Subbiah and César Núnêz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Branko Cuglievan

63 papers receiving 555 citations

Peers

Countries citing papers authored by Branko Cuglievan

Since Specialization

Citations

This map shows the geographic impact of Branko Cuglievan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branko Cuglievan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branko Cuglievan more than expected).

Fields of papers citing papers by Branko Cuglievan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Branko Cuglievan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branko Cuglievan. The network helps show where Branko Cuglievan may publish in the future.

Co-authorship network of co-authors of Branko Cuglievan

This figure shows the co-authorship network connecting the top 25 collaborators of Branko Cuglievan. A scholar is included among the top collaborators of Branko Cuglievan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Branko Cuglievan. Branko Cuglievan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma 2025 ·Cancer Epidemiology Biomarkers & Prevention ·Kelsey L. Corrigan, Amy M. Berkman, Jillian R. Gunther, Clark R. Andersen, Susan Wu, (unknown), Branko Cuglievan, (unknown), (unknown), Penny Fang, Brian De, Sairah Ahmed, César Núnêz, Michelle A.T. Hildebrandt, David McCall, Susan K. Parsons, Michael Roth	0
2	Multimodal spatial proteomic profiling in acute myeloid leukemia 2025 ·npj Precision Oncology ·(unknown), (unknown), (unknown), (unknown), Fatima Zahra Jelloul, Sammy Ferri‐Borgogno, (unknown), Javier A. Gomez, (unknown), Patrick K. Reville, Sonali Jindal, Sreyashi Basu, Padmanee Sharma, Andres Quesada, Carlos E. Bueso‐Ramos, Taghi Manshouri, Branko Cuglievan, (unknown), Jared K. Burks, Hussein A. Abbas	0
3	Risk of early death after acute leukemia diagnosis among adolescents and young adults 2025 ·JNCI Cancer Spectrum ·Amy M. Berkman, Clark R. Andersen, (unknown), Nicholas J. Short, Kelly W. Merriman, Mahesh Swaminathan, Branko Cuglievan, David McCall, Courtney D. DiNardo, César Núnêz, Nitin B. Jain, Tapan M. Kadia, Ghayas C. Issa, (unknown), (unknown), J. Andrew Livingston, Susan K. Parsons, Michelle A.T. Hildebrandt, Michael Roth	0
4	Beyond Cellular Therapies: The Expanding Role of Antibody-Driven Immunotherapy in Pediatric Acute Lymphoblastic Leukemia 2025 ·Acta Haematologica ·David McCall, (unknown), Ramya Ramakrishnan, Priti Tewari, (unknown), (unknown), César Núnêz, (unknown), Branko Cuglievan	0
5	Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia 2025 ·Blood Advances ·(unknown), David McCall, (unknown), (unknown), César Núnêz, Michael Roth, (unknown), Demetrios Petropoulos, Priti Tewari, Branko Cuglievan, (unknown)	1
6	Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncology 2025 ·Nature Reviews Clinical Oncology ·Branko Cuglievan, Vivek Subbiah	2
7	APAL2020K/ITCC-101: A Phase I Trial of the Menin Inhibitor Ziftomenib in Combination with Chemotherapy in Children with Relapsed/Refractory KMT2A-rearranged, NUP98-rearranged, or NPM1-mutant Acute Leukemias 2024 ·Blood ·Elisabeth Salzer, Janine Stutterheim, Branko Cuglievan, Blake Tomkinson, Mollie Leoni, Harm van Tinteren, Alwin D. R. Huitema, Marieke Willemse, Gwen Nichols, Francisco Bautista, Sarah K. Tasian, Todd M. Cooper, C. Michel Zwaan	1
8	A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine (ZiVA) in Pediatric Relapsed and Refractory Acute Leukemias 2024 ·Blood ·David McCall, Branko Cuglievan, (unknown), (unknown), (unknown), César Núnêz	2
9	Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience 2024 ·Cancers ·David McCall, (unknown), (unknown), (unknown), (unknown), Ramya Ramakrishnan, César Núnêz, Michael Roth, (unknown), (unknown), Naval Daver, Sofía Garcés, Nicholas J. Short, Ghayas C. Issa, Farhad Ravandi, Courtney D. DiNardo, Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero, Branko Cuglievan, Tapan M. Kadia	1
10	Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia 2024 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David McCall, César Núnêz, Michael Roth, Priti Tewari, Sofía Garcés, Branko Cuglievan, (unknown)	3
11	Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Nicholas J. Short, Elias Jabbour, (unknown), Shilpa Paul, Branko Cuglievan, David McCall, (unknown), Nitin Jain, Fadi Haddad, Lewis Nasr, Kayleigh Marx, Caitlin R. Rausch, (unknown), Rebecca Garris, Farhad Ravandi, Hagop M. Kantarjian	11
12	Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation 2023 ·Cancer ·Daniel Nguyen, Hagop M. Kantarjian, Nicholas J. Short, Wei Qiao, Jing Ning, Branko Cuglievan, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Tapan M. Kadia, Gautam Borthakur, Guillermo Garcia‐Manero, Marina Konopleva, Michael Andreeff, Farhad Ravandi‐Kashani, Koji Sasaki, Ghayas C. Issa	9
13	Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Branko Cuglievan, Chitra Hosing, Priti Tewari, Sajad Khazal	15
14	Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Amy M. Berkman, Clark R. Andersen, Branko Cuglievan, David McCall, Philip J. Lupo, Susan K. Parsons, Courtney D. DiNardo, Nicholas J. Short, Nitin Jain, Tapan M. Kadia, J. Andrew Livingston, Michael Roth	11
15	Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia 2021 ·Blood Advances ·David McCall, Michael Roth, Kris M. Mahadeo, (unknown), César Núnêz, Nicholas J. Short, Naval Daver, Tapan M. Kadia, Courtney D. DiNardo, (unknown), Branko Cuglievan	6
16	Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma 2021 ·Cancer Gene Therapy ·Salah-Eddine Lamhamedi-Cherradi, (unknown), Dhruva K. Mishra, (unknown), (unknown), (unknown), (unknown), David McCall, Danh D. Truong, Branko Cuglievan, Brian A. Menegaz, Budi Utama, Najat C. Daw, (unknown), Rafał Zieliński, J. Andrew Livingston, Richard Görlick, Antonios G. Mikos, Min P. Kim, Joseph A. Ludwig	25
17	Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma 2021 ·Cancers ·(unknown), (unknown), David McCall, Sajad Khazal, (unknown), (unknown), Michael Roth, Kris M. Mahadeo, César Núnêz, Nicholas J. Short, Courtney D. DiNardo, Marina Konopleva, Ghayas C. Issa, Farhad Ravandi, Nitin Jain, Gautam Borthakur, Hagop M. Kantarjian, Elias Jabbour, Branko Cuglievan	41
18	DNMT3A Mutations Should be Considered in the Risk Stratification for Pediatric and Adolescent and Young Adult Patients with Acute Myeloid Leukemia 2021 ·Blood ·Dristhi Ragoonanan, (unknown), (unknown), César Núnêz, Michael Roth, David McCall, Branko Cuglievan, Priti Tewari, Demetrios Petropoulos, Kris M. Mahadeo, Sajad Khazal	0
19	3D Tissue-Engineered Tumor Model for Ewing’s Sarcoma That Incorporates Bone-like ECM and Mineralization 2019 ·ACS Biomaterials Science & Engineering ·(unknown), (unknown), (unknown), Gerry L. Koons, Brian A. Menegaz, (unknown), Salah-Eddine Lamhamedi-Cherradi, (unknown), (unknown), Branko Cuglievan, Mollie M. Smoak, David W. Scott, Joseph A. Ludwig, Antonios G. Mikos	21
20	Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival 2018 ·Clinical Cancer Research ·Vivek Subbiah, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, Brian A. Menegaz, (unknown), Winston W. Huh, Vandhana Ramamoorthy, Pete Anderson, Raphael E. Pollock, Dina Lev, Wei Qiao, Mary Frances McAleer, Robert S. Benjamin, Shreyaskumar Patel, Cynthia E. Herzog, Najat C. Daw, Barry W. Feig, Alexander J. Lazar, Andrea Hayes‐Jordan, Joseph A. Ludwig	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact